These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19069460)

  • 21. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].
    Kong WM; Gong J; Dong L; Chen MX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
    Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
    Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
    Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].
    Makarchuk PA; Golovenko OV; Mikhaĭlova TL; Podmarenkova LF
    Eksp Klin Gastroenterol; 2005; (1):25-9. PubMed ID: 15991849
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H; Merat S; Momtahen S; Kazzazi AS; Ghaffari N; Olfati G; Malekzadeh R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):678-84. PubMed ID: 18248658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
    Andrews CN; Griffiths TA; Kaufman J; Vergnolle N; Surette MG; Rioux KP
    Aliment Pharmacol Ther; 2011 Aug; 34(3):374-83. PubMed ID: 21671966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D; Schulte-Witte H
    Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal spirochetosis and chronic watery diarrhea: clinical and histological response to treatment and long-term follow up.
    Esteve M; Salas A; Fernández-Bañares F; Lloreta J; Mariné M; Gonzalez CI; Forné M; Casalots J; Santaolalla R; Espinós JC; Munshi MA; Hampson DJ; Viver JM
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1326-33. PubMed ID: 16872318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective evaluation of the diagnostic value of video capsule endoscopy in patients initially classified as irritable bowel syndrome.
    Ohlsson B; Bengtsson M; Nielsen J; Toth E
    Eur J Intern Med; 2009 Jan; 20(1):48-52. PubMed ID: 19237092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course].
    Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T
    Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
    Kane JS; Ford AC
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
    Yakovenko EP; Strokova TV; Ivanov AN; Iakovenko AV; Gioeva IZ; Aldiyarova MA
    Ter Arkh; 2022 Feb; 94(2):180-187. PubMed ID: 36286741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
    Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
    Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
    Bahar RJ; Collins BS; Steinmetz B; Ament ME
    J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spasmocanulase in irritable bowel syndrome.
    Mohamed AE; Ghandour ZM; Al-Karawi MA
    Saudi Med J; 2002 Sep; 23(9):1074-7. PubMed ID: 12370715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of studies of microorganisms of the intestinal mucosa by culture biochemical methods and mass fragmentography].
    Osipov GA; Parfenov AI; Verkhovtseva NV; Ruchkina IN; Kurchavov VA; Boĭko NB; Rogatina EL
    Eksp Klin Gastroenterol; 2003; (4):59-67, 115. PubMed ID: 14653241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.